|Articles|December 1, 2001
Johns Hopkins licenses rights to retinal therapy
Laurel, MD-The Johns Hopkins University Applied Physics Laboratory(APL) has licensed the international rights to Novadaq Technologies fora patented method for diagnosing and treating age-related macular degeneration(AMD).
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Metformin use associated with reduced incidence of intermediate AMD
2
MeiraGTx Licenses complement-targeted geographic atrophy program from ZipBio
3
Last year in glaucoma at EnVision Summit 2025
4
Looking back at the 2025 EnVision Summit
5
























